ACM
INSP icon

Anfield Capital Management’s Inspire Medical Systems INSP Stock Holding History

Anfield Capital Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20
Closed -$4.3K – 468
2024
Q1 		$4.3K Buy
+20
New +$3.92K ﹤0.01% 220

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Anfield Capital Management's INSP Position: Q2 2024 in Review

Anfield Capital Management sold out of Inspire Medical Systems (INSP) in Q2 2024, closing a stake of 20 shares — an estimated $4.3K sold.

Anfield Capital Management first reported a position in INSP in Q1 2024 and held it in 1 quarter. The position peaked at $4.3K in Q1 2024. 325 funds tracked by Wall St. Rank hold INSP as of Q2 2024.

  • Anfield Capital Management reported no remaining Inspire Medical Systems position as of Q2 2024 after selling out during the quarter.
  • Anfield Capital Management sold 20 Inspire Medical Systems shares in Q2 2024, an estimated $4.3K.
  • Anfield Capital Management first reported a position in Inspire Medical Systems in Q1 2024 and held it in 1 quarter.
  • Anfield Capital Management's Inspire Medical Systems position peaked at $4.3K in Q1 2024.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2024.

Based on Anfield Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.